Abridge Partners With NEJM & JAMA Network to Expand AI Clinical Decision Support

Under the collaboration, content from NEJM and JAMA Network will be integrated into Abridge’s AI system to inform responses when clinicians query medical information or seek guidance related to patient treatment.

AI healthcare company Abridge has expanded its clinical decision support capabilities through new partnerships with the New England Journal of Medicine (NEJM) and the JAMA Network, aiming to streamline access to medical research for clinicians during patient care.

Under the collaboration, content from NEJM and JAMA Network will be integrated into Abridge’s AI system to inform responses when clinicians query medical information or seek guidance related to patient treatment. The company said the update is designed to help providers quickly access relevant, evidence-based research at the point of care.

The expanded capability builds on Abridge’s existing partnerships, which already include Wolters Kluwer’s UpToDate clinical and drug information platform. According to the company, clinicians have been using the updated decision support features for the past two to three months, with NEJM and JAMA content expected to roll out in the coming months.

Abridge, founded in 2018, is part of a growing group of companies developing generative AI tools for clinical documentation and decision support. The platform is currently used across more than 250 health systems in the United States, including Kaiser Permanente, UPMC, and Northwell Health.

The company said clinicians can use the tool before, during, and after patient interactions to retrieve relevant information from clinical notes and external medical literature. The system also allows providers to query the AI for preparation ahead of appointments.

To address accuracy concerns, Abridge said responses generated through the platform include source annotations, allowing clinicians to verify the origin of information and reduce the risk of incorrect outputs.

Industry adoption of AI tools in healthcare has increased in recent years. According to a survey by Doximity, 35% of physicians reported using AI tools to search for recent research to support clinical decisions, while nearly 30% use voice-based documentation tools for clinical note generation.

Abridge said the integration of peer-reviewed medical journal content is intended to improve access to updated research within clinical workflows while maintaining clinician control over final medical decisions.

Stay tuned for more such updates on Digital Health News